Support our work
Decorative header background

The role of central dopamine and serotonin in human obesity: lessons learned from molecular neuroimaging studies

Research group la Fleur
Publication year 2018
Published in Metabolism: Clinical and Experimental
Authors Katy A van Galen, Kasper W Ter Horst, Jan Booij, S.E. La Fleur, Mireille J Serlie

Obesity results from an imbalance between energy intake and expenditure, and many studies have aimed to determine why obese individuals continue to (over)consume food under conditions of caloric excess. The two major “neurotransmitter hypotheses” of obesity state that increased food intake is partially driven by decreased dopamine-mediated reward and decreased serotonin-mediated homeostatic feedback in response to food intake. Using molecular neuroimaging studies to visualize and quantify aspects of the central dopamine and serotonin systems in vivo, recent PET and SPECT studies have also implicated alterations in these systems in human obesity. The interpretation of these data, however, is more complex than it may appear. Here, we discuss important characteristics and limitations of current radiotracer methods and use this framework to comprehensively review the available human data on central dopamine and serotonin in obesity. On the basis of the available evidence, we conclude that obesity is associated with decreased central dopaminergic and serotonergic signaling and that future research, especially in long-term follow-up and interventional settings, is needed to advance our understanding of the neuronal pathophysiology of obesity in humans.

Support our work!

The Friends Foundation facilitates groundbreaking brain research. You can help us with that.

Support our work